Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DABI-ADP-2
2011-000504-18Phase 4Completed
- Sponsor
- Deutsches Herzzentrum München
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Atrial fibrillation (AFib) and coronary arteriosclerosis comparing Dabigatran + clopidogrel with Phenprocoumon + clopidogrel (2 arms). Primary endpoint: Maximal ADP-induced platelet aggregation at day 14. Started Feb 2011; status: completed.
02
Drugs
dabigatranphenprocoumon
03
Conditions
Atrial fibrillation (AFib)coronary arteriosclerosis
Beyond the preview
Go deeper on 2011-000504-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000504-18.